by Jordana Choucair | Oct 7, 2022 | Life Sciences
U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra said the agency would “continue to explore every option we have” with regard to lowering drug prices. According to Becerra, even utilizing so-called march-in rights — power granted...
by Jordana Choucair | Oct 7, 2022 | Life Sciences
Center for Medicare Director Meena Seshamani said drugmakers who raise prices on medicines for patients with private insurance will still face penalties under the Inflation Reduction Act’s drug pricing law. If drugmakers increase prices faster than the rate of...
by Jordana Choucair | Oct 7, 2022 | Payers
The Centers for Medicare & Medicaid Services (CMS) released Medicare Advantage (MA) plan star ratings, revealing the average rating for the private plans has fallen compared to last year. The average rating across all plans is 4.15 out of a possible 5 stars for...
by Jordana Choucair | Oct 7, 2022 | Payers
Mark Cuban Cost Plus Drug Company announced its first health plan partner, Capital Blue Cross. Beginning this month, the companies will notify members and community organizations about their collaboration and how they can access low-cost drugs. In 2023, Capital Blue...
by Jordana Choucair | Oct 7, 2022 | Public Health/Prevention
The National Youth Tobacco Survey found that roughly 2.55 million U.S. middle and high school students reported vaping this year, with 84.5 percent of those using flavored e-cigarettes. The survey, conducted by the Centers for Disease Control and Prevention and the...
by Jordana Choucair | Oct 6, 2022 | Health IT
Effective today, new federal rules will require health care organizations to grant patients unrestricted access to their full health records in digital format. Passed under the 21st Century Cures Act, the rules are designed to not only ensure that patients can access...
Recent Comments